title: Sumatriptan/naproxen sodium: a review of its use in adult patients with migraine.
abstract: A fixed-dose combination of sumatriptan/naproxen sodium (Treximet(®)) has been approved in the US for the acute treatment of migraine in adults. In two randomized trials, sumatriptan/naproxen sodium demonstrated significantly better efficacy than sumatriptan alone, naproxen sodium alone, or placebo as late-intervention therapy for a single migraine episode in adults, as assessed by co-primary efficacy endpoints evaluating pain and other migraine-related symptoms, as well as health-related quality of life (HR-QOL) endpoints. In four other randomized trials, the drug combination was also effective as early intervention in adults with migraine (including those with menstrual migraine and dysmenorrhoea, or those with poor response or intolerance to triptan therapy) according to various pain-related primary efficacy and HR-QOL endpoints. Data from longer-term, non-randomized studies support these findings, and the drug combination appears to be beneficial in patients with migraine and cutaneous allodynia. In clinical trials, sumatriptan/naproxen sodium was generally well tolerated, with an overall tolerability profile similar to that of sumatriptan. The most common adverse events were in line with those expected for sumatriptan and naproxen sodium. Current data indicate that sumatriptan/naproxen sodium is a useful option in the treatment of adult migraine.
authors.affiliation: Adis, 41 Centorian Drive, Private Bag 65901, Mairangi Bay, North Shore, 0754 Auckland, New Zealand. demail@springer.com
authors.forename: Lily P H
authors.initials: LP
authors.lastname: Yang
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use*; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D006801:Humans; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy*; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D058825:Serotonin 5-HT1 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D018170:Sumatriptan / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D058825:Serotonin 5-HT1 Receptor Agonists; D009288:Naproxen; D018170:Sumatriptan
references.citation: Drugs. 2012 Dec 3;72(17):2187-205
references.pmid: 23116251
references.citation: CNS Drugs. 2012 May 1;26(5):375-82
references.pmid: 22519921
references.citation: Circulation. 2007 Mar 27;115(12):1634-42
references.pmid: 17325246
references.citation: Headache. 2012 Sep;52(8):1323-4
references.pmid: 22946836
references.citation: JAMA. 2000 Nov 22-29;284(20):2640-1
references.pmid: 11086374
references.citation: Headache. 2012 Apr;52(4):636-47
references.pmid: 22221151
references.citation: CNS Drugs. 2012 Nov;26(11):949-57
references.pmid: 23018546
references.citation: Headache. 2004 May;44(5):414-25
references.pmid: 15147249
references.citation: Headache. 2012 Apr;52(4):672-4
references.pmid: 22404123
references.citation: JAMA. 2000 Nov 22-29;284(20):2599-605
references.pmid: 11086366
references.citation: Eur J Neurol. 2009 Sep;16(9):968-81
references.pmid: 19708964
references.citation: Neurology. 2008 Jul 8;71(2):114-21
references.pmid: 18606965
references.citation: Headache. 2012 Jan;52(1):80-9
references.pmid: 22150557
references.citation: Drugs. 1990 Jul;40(1):91-137
references.pmid: 2202585
references.citation: Cephalalgia. 2007 Mar;27(3):193-210
references.pmid: 17381554
references.citation: Can J Clin Pharmacol. 2000 Winter;7(4):191-7
references.pmid: 11118965
references.citation: J Clin Pharmacol. 2000 Jan;40(1):99-104
references.pmid: 10631628
references.citation: Obstet Gynecol. 2009 Jul;114(1):106-113
references.pmid: 19546766
references.citation: Headache. 2010 Jun;50(6):1089-99
references.pmid: 20618823
references.citation: Drugs. 2000 Dec;60(6):1259-87
references.pmid: 11152011
references.citation: J Pharm Pharm Sci. 2008 Sep 20;11(2):81s-110s
references.pmid: 19203472
references.citation: MedGenMed. 2007 Jun 07;9(2):53
references.pmid: 17955107
references.citation: Headache. 2012 Apr;52(4):530-43
references.pmid: 22103635
references.citation: CNS Drugs. 2012 Oct 1;26(10):823-39
references.pmid: 22823482
references.citation: JAMA. 2007 Apr 4;297(13):1443-54
references.pmid: 17405970
references.citation: Aliment Pharmacol Ther. 1992 Dec;6(6):685-91
references.pmid: 1336675
references.citation: Arq Neuropsiquiatr. 2000 Jun;58(2B):428-30
references.pmid: 10920403
references.citation: Drug Des Devel Ther. 2010 Feb 18;4:9-17
references.pmid: 20368903
references.citation: Headache. 2010 Mar;50(3):357-73
references.pmid: 20132340
references.citation: Neurology. 2000 Sep 26;55(6):754-62
references.pmid: 10993991
references.citation: Headache. 2012 Feb;52(2):198-203
references.pmid: 22289074
references.citation: Headache. 2007 Mar;47(3):355-63
references.pmid: 17371352
references.citation: Neurology. 2007 Jan 30;68(5):343-9
references.pmid: 17261680
references.citation: Cochrane Database Syst Rev. 2012 Feb 15;(2):CD008615
references.pmid: 22336849
references.citation: CNS Drugs. 2007;21(1):73-82
references.pmid: 17190530
references.citation: Curr Clin Pharmacol. 2012 Feb 1;7(1):66-72
references.pmid: 22299771
references.citation: Ann Intern Med. 2002 Nov 19;137(10):840-9
references.pmid: 12435222
references.citation: Cephalalgia. 2009 Aug;29(8):826-36
references.pmid: 19220307
references.citation: Eur J Pain. 2012 Apr;16(4):585-91
references.pmid: 22396086
references.citation: Headache. 2007 May;47(5):683-92
references.pmid: 17501849
references.citation: Headache. 2011 Jun;51(6):961-70
references.pmid: 21592098
references.citation: J Headache Pain. 2005 Dec;6(6):429-40
references.pmid: 16388337
references.citation: J Clin Hypertens (Greenwich). 2011 Dec;13(12):910-6
references.pmid: 22142350
references.citation: BMC Neurol. 2011 Mar 31;11:43
references.pmid: 21453539
references.citation: Mayo Clin Proc. 2007 Jan;82(1):61-8
references.pmid: 17285787
references.citation: CNS Drugs. 2005;19(9):769-84
references.pmid: 16142992
references.citation: Ther Adv Neurol Disord. 2009 May;2(3):135-41
references.pmid: 21179523
references.citation: Dig Liver Dis. 2004 Jan;36(1):85-92
references.pmid: 14971822
references.citation: Headache. 2011 May;51(5):664-73
references.pmid: 21521204
references.citation: BMJ. 2011 Jan 11;342:c7086
references.pmid: 21224324
references.citation: Headache. 2009 Jul;49(7):971-82
references.pmid: 19486178
references.citation: Headache. 2013 Apr;53(4):656-64
references.pmid: 23406052
references.citation: Headache. 2005 Sep;45(8):983-91
references.pmid: 16109111
references.citation: Headache. 2012 Jan;52(1):133-9
references.pmid: 21883200
references.citation: Headache. 2010 May;50(5):808-18
references.pmid: 20236345